CoChat
Sign Up
Cited by 67

The DOI matches its Crossref record.

Role of CD44high/CD133high HCT-116 cells in the tumorigenesis of colon cancer

Zhou, Jin-Yong, Chen, Min, Ma, Long, Wang, Xiaoxiao, Chen, Yu-Gen, Liu, Shen-Lin·2016·Oncotarget
DOI 10.18632/oncotarget.7084PMC PMC4884945
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.7084

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 35

  1. Wild, 2014, In world cancer report
  2. Huang, 2014, The colon cancer stem cell microenvironment holds keys to future cancer therapy, J Gastrointest Surg, 18, 1040, 10.1007/s11605-014-2497-1 · DOI
  3. Medema, 2013, Cancer heterogeneity - a multifaceted view, EMBO Rep, 14, 686, 10.1038/embor.2013.92 · DOI
  4. De maria, 2014, Colorectal cancer stem cells: from the crypt to the clinic, Cell Stem Cell, 15, 692, 10.1016/j.stem.2014.11.012 · DOI
  5. Dick, 2007, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature, 445, 106, 10.1038/nature05372 · DOI
  6. De Maria, 2007, Identification and expansion of human colon-cancer-initiating cells, Nature, 445, 111, 10.1038/nature05384 · DOI
  7. Stassi, 2007, Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4, Cell Stem Cell, 1, 389, 10.1016/j.stem.2007.08.001 · DOI
  8. De Maria, 2014, CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis, Cell Stem Cell, 14, 342, 10.1016/j.stem.2014.01.009 · DOI
  9. Qian, 2013, characterization of stem cell-like properties of drug-resistant colon cancer subline, Oncol Res, 21, 51, 10.3727/096504013X13793555706768 · DOI
  10. Macarthur, 2014, Collective dynamics of stem cell populations, Proc Natl Acad Sci USA, 111, 3653, 10.1073/pnas.1401030111 · DOI
  11. Yamanaka, 2014, Rethinking differentiation: stem cells, regeneration, and plasticity, Cell, 157, 110, 10.1016/j.cell.2014.02.041 · DOI
  12. Li, 2013, CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis, PLoS ONE, 8, e56380, 10.1371/journal.pone.0056380 · DOI
  13. Zhang, 2009, Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB, J Transl Med, 7, 56, 10.1186/1479-5876-7-56 · DOI
  14. Jung, 2009, Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer, Cancer Invest, 27, 844, 10.1080/07357900902744502 · DOI
  15. Dick, 2014, Evolution of the cancer stem cell model, Cell Stem Cell, 14, 275, 10.1016/j.stem.2014.02.006 · DOI
  16. Nestor, 2014, Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells, PLoS ONE, 9, e94621, 10.1371/journal.pone.0094621 · DOI · Paper page
  17. Zeidan, 2014, Stem cells in gastrointestinal cancers: The road less travelled, World J Stem Cells, 6, 606, 10.4252/wjsc.v6.i5.606 · DOI
  18. Schuler, 2012, Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker, BMC Cancer, 12, 96, 10.1186/1471-2407-12-96 · DOI · Paper page
  19. Cheng, 2014, Characterization of side population cells isolated from the colon cancer cell line SW480, Int J Oncol, 45, 1175, 10.3892/ijo.2014.2498 · DOI
  20. Guo, 2014, ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer, Oncol Res Treat, 37, 666, 10.1159/000368842 · DOI
  21. Szaro, 2012, Heterogeneous nuclear ribonucleoprotein K, an RNA-binding protein, is required for optic axon regeneration in Xenopus laevis, J Neurosci, 32, 3563, 10.1523/JNEUROSCI.5197-11.2012 · DOI
  22. Szaro, 2011, hnRNP K post-transcriptionally co-regulates multiple cytoskeletal genes needed for axonogenesis, Development, 138, 3079, 10.1242/dev.066993 · DOI
  23. Szaro, 2008, A crucial role for hnRNP K in axon development in Xenopus laevis, Development, 135, 3125, 10.1242/dev.022236 · DOI
  24. Bodmer, 2010, Cancer stem cells from colorectal cancer-derived cell lines, Proc Natl Acad Sci USA, 107, 3722, 10.1073/pnas.0915135107 · DOI
  25. Botchkina, 2009, Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis, Cancer Genomics Proteomics, 6, 19
  26. Dirks, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128 · DOI
  27. Frank, 2003, Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter, J Biol Chem, 278, 47156, 10.1074/jbc.M308700200 · DOI
  28. Clarke, 2003, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci USA, 100, 3983, 10.1073/pnas.0530291100 · DOI
  29. Liu, 2013, CD133 affects the invasive ability of HCT116 cells by regulating TIMP-2, Am J Pathol, 182, 565, 10.1016/j.ajpath.2012.10.015 · DOI
  30. Yu, 2006, Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma, Mol Cancer, 5, 67, 10.1186/1476-4598-5-67 · DOI
  31. Voest, 2006, Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases, Clin Cancer Res, 12, 4859, 10.1158/1078-0432.CCR-06-0422 · DOI
  32. Kim, 2015, Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases, Int J Oncol, 46, 1582, 10.3892/ijo.2015.2844 · DOI
  33. Tanaka, 2010, Characteristics of CD133(+) human colon cancer SW620 cells, Cell Transplant, 19, 857, 10.3727/096368910X508988 · DOI
  34. Kahn, 2011, Common cancer stem cell gene variants predict colon cancer recurrence, Clin Cancer Res, 17, 6934, 10.1158/1078-0432.CCR-11-1180 · DOI
  35. Theodoropoulos, 2011, Stem cells in colon cancer. A new era in cancer theory begins, Int J Colorectal Dis, 26, 1, 10.1007/s00384-010-1022-6 · DOI

Cited by

Sorted by citations

See all 67

Metadata

Authors
Zhou, J.-Y., Chen, M., Ma, L., Wang, X., Chen, Y.-G., & Liu, S.-L.
Affiliations
  • Central Laboratory, The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China
  • Department of Internal Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China
  • Department of Urology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China
  • Department of Medical Science Research, The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China
  • Department of Colorectal Surgery, The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China
  • Department of Oncology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China
Venue
Oncotarget
Publisher
Impact Journals, LLC
Published
2016-01-30
Volume
7
Issue
7
Pages
7657-7666
ISSN
1949-2553
DOI
10.18632/oncotarget.7084
PMC
PMC4884945
Cited by
67
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review